Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. | CLPT | $13.96 | $425.84M | — | |
| Rocket Pharmaceuticals, Inc. | RCKT | $3.86 | $423.73M | — | |
| PureTech Health plc | PRTC | $17.38 Jul 17, 2026 | $419.90M | — | |
| Pacific Biosciences of California, Inc. | PACB | $1.35 | $419.62M | — | |
| 908 Devices Inc. | MASS | $10.05 | $415.40M | — | |
| Cybin Inc. | CYBN | $6.81 Feb 20, 2026 | $413.12M | — | |
| Enanta Pharmaceuticals, Inc. | ENTA | $14.08 | $410.09M | — | |
| Community Health Systems, Inc. | CYH | $2.89 | $407.52M | 1.6 | — |
| Lexeo Therapeutics, Inc. | LXEO | $4.89 | $401.21M | — | |
| X4 Pharmaceuticals, Inc. | XFOR | $4.04 | $400.55M | 2.8 | — |
| Larimar Therapeutics, Inc. | LRMR | $3.83 | $397.87M | — | |
| Auna SA | AUNA | $5.28 | $391.02M | 88.0 | — |
| TruBridge, Inc. | TBRG | $26.24 Jul 13, 2026 | $389.23M | 89.5 | — |
| Opus Genetics, Inc. | IRD | $4.67 | $388.52M | — | |
| Mobia Medical, Inc. | MOBI | $11.63 | $387.18M | — | |
| EyePoint, Inc. | EYPT | $4.58 | $383.99M | — | |
| Century Therapeutics, Inc. | IPSC | $2.11 | $382.07M | — | |
| Zentalis Pharmaceuticals, Inc. | ZNTL | $3.99 | $377.74M | — | |
| Orthofix Medical Inc. | OFIX | $9.29 | $375.52M | — | |
| Simulations Plus, Inc. | SLP | $18.43 | $372.74M | 46.1 | — |
| Alpha Teknova, Inc. | TKNO | $6.92 | $371.52M | — | |
| Agenus Inc. | AGEN | $8.24 | $370.88M | 2.8 | — |
| Spectral Medical Inc. | EDT.TO | CA$1.26 | CA$369.88M | — | |
| Cipher Pharmaceuticals Inc. | CPH.TO | CA$14.34 | CA$364.45M | 9.2 | — |
| Palisade Bio, Inc. | PALI | $2.09 | $364.23M | 3.2 | — |
| DiaMedica Therapeutics Inc. | DMAC | $6.75 | $364.00M | — | |
| Perspective Therapeutics, Inc. | CATX | $3.13 | $357.29M | — | |
| Q32 Bio Inc. | QTTB | $11.99 | $356.94M | 3.8 | — |
| TerrAscend Corp. | TSND.TO | CA$0.95 | CA$354.03M | — | |
| Lyell Immunopharma, Inc. | LYEL | $14.37 | $352.14M | — | |
| Inhibikase Therapeutics, Inc. | IKT | $2.50 | $348.84M | — | |
| Profound Medical Corp. | PRN.TO | CA$9.54 | CA$348.59M | — | |
| AVITA Medical, Inc. | RCEL | $11.20 | $346.38M | — | |
| Viemed Healthcare, Inc. | VMD | $9.08 | $345.84M | 25.2 | — |
| Abeona Therapeutics Inc. | ABEO | $6.00 | $343.10M | — | |
| SAB Biotherapeutics, Inc. | SABS | $3.72 | $338.47M | 15.5 | — |
| Sutro Biopharma, Inc. | STRO | $20.07 | $332.78M | — | |
| Upstream Bio, Inc. | UPB | $6.01 | $329.17M | — | |
| Clinuvel Pharmaceuticals Limited | CUVL | $6.52 | $328.79M | 13.6 | 0.58% |
| Embecta Corp. | EMBC | $5.80 | $328.63M | 3.9 | 0.69% |
| Vanda Pharmaceuticals Inc. | VNDA | $5.43 | $328.31M | — | |
| Auxly Cannabis Group Inc. | XLY.TO | CA$3.18 | CA$328.29M | 10.3 | — |
| InflaRx N.V. Common Stock | IFRX | $2.22 | $327.16M | — | |
| Vicore Pharma Holding AB (publ) | VCRE | $11.59 | $326.29M | — | |
| Cellectis S.A. | CLLS | $3.24 | $326.27M | — | |
| Pyxis Oncology, Inc. | PYXS | $3.89 | $324.46M | — | |
| Sionna Therapeutics, Inc. | SION | $7.18 | $324.18M | — | |
| Sanara MedTech Inc. | SMTI | $34.73 | $319.10M | — | |
| Emergent BioSolutions Inc. | EBS | $6.21 | $318.41M | — | |
| Treace Medical Concepts, Inc. | TMCI | $4.81 | $312.82M | — |
ClearPoint Neuro, Inc.
Healthcare / Medical Devices
- Market Cap
- $425.84M
- P/E
- unprofitable
Rocket Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $423.73M
- P/E
- unprofitable
PureTech Health plc
Healthcare / Biotechnology
- Market Cap
- $419.90M
- P/E
- unprofitable
Pacific Biosciences of California, Inc.
Healthcare / Medical Devices
- Market Cap
- $419.62M
- P/E
- unprofitable
908 Devices Inc.
Healthcare / Medical Devices
- Market Cap
- $415.40M
- P/E
- unprofitable
Cybin Inc.
Healthcare / Biotechnology
- Market Cap
- $413.12M
- P/E
- unprofitable
Enanta Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $410.09M
- P/E
- unprofitable
Community Health Systems, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $407.52M
- P/E
- 1.6
Lexeo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $401.21M
- P/E
- unprofitable
X4 Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $400.55M
- P/E
- 2.8
Larimar Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $397.87M
- P/E
- unprofitable
Auna SA
Healthcare / Medical Care Facilities
- Market Cap
- $391.02M
- P/E
- 88.0
TruBridge, Inc.
Healthcare / Health Information Services
- Market Cap
- $389.23M
- P/E
- 89.5
Opus Genetics, Inc.
Healthcare / Biotechnology
- Market Cap
- $388.52M
- P/E
- unprofitable
Mobia Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $387.18M
- P/E
- unprofitable
EyePoint, Inc.
Healthcare / Biotechnology
- Market Cap
- $383.99M
- P/E
- unprofitable
Century Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $382.07M
- P/E
- unprofitable
Zentalis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $377.74M
- P/E
- unprofitable
Orthofix Medical Inc.
Healthcare / Medical Devices
- Market Cap
- $375.52M
- P/E
- unprofitable
Simulations Plus, Inc.
Healthcare / Health Information Services
- Market Cap
- $372.74M
- P/E
- 46.1
Alpha Teknova, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $371.52M
- P/E
- unprofitable
Agenus Inc.
Healthcare / Biotechnology
- Market Cap
- $370.88M
- P/E
- 2.8
Spectral Medical Inc.
Healthcare / Diagnostics & Research
- Market Cap
- CA$369.88M
- P/E
- unprofitable
Cipher Pharmaceuticals Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$364.45M
- P/E
- 9.2
Palisade Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $364.23M
- P/E
- 3.2
DiaMedica Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $364.00M
- P/E
- unprofitable
Perspective Therapeutics, Inc.
Healthcare / Medical Devices
- Market Cap
- $357.29M
- P/E
- unprofitable
Q32 Bio Inc.
Healthcare / Biotechnology
- Market Cap
- $356.94M
- P/E
- 3.8
TerrAscend Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$354.03M
- P/E
- unprofitable
Lyell Immunopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $352.14M
- P/E
- unprofitable
Inhibikase Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $348.84M
- P/E
- unprofitable
Profound Medical Corp.
Healthcare / Medical Devices
- Market Cap
- CA$348.59M
- P/E
- unprofitable
AVITA Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $346.38M
- P/E
- unprofitable
Viemed Healthcare, Inc.
Healthcare / Medical Devices
- Market Cap
- $345.84M
- P/E
- 25.2
Abeona Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $343.10M
- P/E
- unprofitable
SAB Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $338.47M
- P/E
- 15.5
Sutro Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $332.78M
- P/E
- unprofitable
Upstream Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $329.17M
- P/E
- unprofitable
Clinuvel Pharmaceuticals Limited
Healthcare / Biotechnology
- Market Cap
- $328.79M
- P/E
- 13.6
- Dividend Yield
- 0.58%
Embecta Corp.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $328.63M
- P/E
- 3.9
- Dividend Yield
- 0.69%
Vanda Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $328.31M
- P/E
- unprofitable
Auxly Cannabis Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$328.29M
- P/E
- 10.3
InflaRx N.V. Common Stock
Healthcare / Biotechnology
- Market Cap
- $327.16M
- P/E
- unprofitable
Vicore Pharma Holding AB (publ)
Healthcare / Biotechnology
- Market Cap
- $326.29M
- P/E
- unprofitable
Cellectis S.A.
Healthcare / Biotechnology
- Market Cap
- $326.27M
- P/E
- unprofitable
Pyxis Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $324.46M
- P/E
- unprofitable
Sionna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $324.18M
- P/E
- unprofitable
Sanara MedTech Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $319.10M
- P/E
- unprofitable
Emergent BioSolutions Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $318.41M
- P/E
- unprofitable
Treace Medical Concepts, Inc.
Healthcare / Medical Devices
- Market Cap
- $312.82M
- P/E
- unprofitable
Showing 551–600 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.